MaRS News Roundup – November 2023

Published on November 2, 2023

A new initiative to improve youth mental health, the world’s first FDA-cleared MRI-compatible surgical robot and a conversational AI platform raising stroke awareness — catch up on our latest MaRS Monthly.

The post MaRS News Roundup – November 2023 appeared first on MaRS Discovery District.

Continue reading on website
Other news

Innovating the Canadian Biotech Sector with Joseph Mancini, adMare BioInnovations

November 2, 2023
As Vice President of Research, Dr. Joseph Mancini plays a central role in leading adMare’s R&D team and the strategic development and advancement of adMare’s pipeline of drug development projects to support the building of strong Canadian life sciences companies. Joe brings more than 30 years of experience in drug discovery to the role and is responsible for overseeing the biology and pharmacology

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results

November 3, 2023
Net product revenue of $40.8 million for the third quarter of 2023; an increase of 60% over the prior year third quarter Total net revenue of $130.4 million for the nine months ended September 30, 2023, an increase of 24% over prior year Achieved European pricing and reimbursement milestone triggering $10 million payment from Otsuka Pharmaceutical Co. Ltd. Narrowing 2023 net product revenue guidan